BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 37190064)

  • 1. Pathophysiological Impact of the MEK5/ERK5 Pathway in Oxidative Stress.
    Tusa I; Menconi A; Tubita A; Rovida E
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erk5 inhibits endothelial migration via KLF2-dependent down-regulation of PAK1.
    Komaravolu RK; Adam C; Moonen JR; Harmsen MC; Goebeler M; Schmidt M
    Cardiovasc Res; 2015 Jan; 105(1):86-95. PubMed ID: 25388666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEK5 and ERK5 are localized in the nuclei of resting as well as stimulated cells, while MEKK2 translocates from the cytosol to the nucleus upon stimulation.
    Raviv Z; Kalie E; Seger R
    J Cell Sci; 2004 Apr; 117(Pt 9):1773-84. PubMed ID: 15075238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin-dependent regulation of MEKK2/3-MEK5-ERK5 signaling module by XIAP and cIAP1.
    Takeda AN; Oberoi-Khanuja TK; Glatz G; Schulenburg K; Scholz RP; Carpy A; Macek B; Remenyi A; Rajalingam K
    EMBO J; 2014 Aug; 33(16):1784-801. PubMed ID: 24975362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YAP promotes myogenic differentiation
    Chen TH; Chen CY; Wen HC; Chang CC; Wang HD; Chuu CP; Chang CH
    FASEB J; 2017 Jul; 31(7):2963-2972. PubMed ID: 28356344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement of the MEK5-ERK5 pathway for neural differentiation in Xenopus embryonic development.
    Nishimoto S; Kusakabe M; Nishida E
    EMBO Rep; 2005 Nov; 6(11):1064-9. PubMed ID: 16179948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The MEK5/ERK5 Pathway in Health and Disease.
    Paudel R; Fusi L; Schmidt M
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PB1 domain-dependent signaling complex is required for extracellular signal-regulated kinase 5 activation.
    Nakamura K; Uhlik MT; Johnson NL; Hahn KM; Johnson GL
    Mol Cell Biol; 2006 Mar; 26(6):2065-79. PubMed ID: 16507987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MEK5/ERK5 mitogen-activated protein kinase cascade is an effector pathway of bone-sustaining bisphosphonates that regulates osteogenic differentiation and mineralization.
    Adam C; Glück L; Ebert R; Goebeler M; Jakob F; Schmidt M
    Bone; 2018 Jun; 111():49-58. PubMed ID: 29567200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEK5 is activated by shear stress, activates ERK5 and induces KLF4 to modulate TNF responses in human dermal microvascular endothelial cells.
    Clark PR; Jensen TJ; Kluger MS; Morelock M; Hanidu A; Qi Z; Tatake RJ; Pober JS
    Microcirculation; 2011 Feb; 18(2):102-17. PubMed ID: 21166929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MEK5-ERK5 Kinase Axis Controls Lipid Metabolism in Small-Cell Lung Cancer.
    Cristea S; Coles GL; Hornburg D; Gershkovitz M; Arand J; Cao S; Sen T; Williamson SC; Kim JW; Drainas AP; He A; Cam LL; Byers LA; Snyder MP; Contrepois K; Sage J
    Cancer Res; 2020 Mar; 80(6):1293-1303. PubMed ID: 31969375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MEK5/ERK5 signalling pathway in cancer: a promising novel therapeutic target.
    Simões AE; Rodrigues CM; Borralho PM
    Drug Discov Today; 2016 Oct; 21(10):1654-1663. PubMed ID: 27320690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mitogen-activated protein kinase docking site in the N terminus of MEK5alpha organizes the components of the extracellular signal-regulated kinase 5 signaling pathway.
    Seyfried J; Wang X; Kharebava G; Tournier C
    Mol Cell Biol; 2005 Nov; 25(22):9820-8. PubMed ID: 16260599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype.
    Zhou C; Nitschke AM; Xiong W; Zhang Q; Tang Y; Bloch M; Elliott S; Zhu Y; Bazzone L; Yu D; Weldon CB; Schiff R; McLachlan JA; Beckman BS; Wiese TE; Nephew KP; Shan B; Burow ME; Wang G
    Breast Cancer Res; 2008; 10(6):R105. PubMed ID: 19087274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of either ERK1/2 or ERK5 MAP kinase pathways can lead to disruption of the actin cytoskeleton.
    Barros JC; Marshall CJ
    J Cell Sci; 2005 Apr; 118(Pt 8):1663-71. PubMed ID: 15797923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MEK5/ERK5 pathway mediates fluid shear stress promoted osteoblast differentiation.
    Zhao LG; Chen SL; Teng YJ; An LP; Wang J; Ma JL; Xia YY
    Connect Tissue Res; 2014 Apr; 55(2):96-102. PubMed ID: 24111522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant extracellular signal-regulated kinase (ERK) 5 signaling in hippocampus of suicide subjects.
    Dwivedi Y; Rizavi HS; Teppen T; Sasaki N; Chen H; Zhang H; Roberts RC; Conley RR; Pandey GN
    Neuropsychopharmacology; 2007 Nov; 32(11):2338-50. PubMed ID: 17342168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MEK5 and ERK5 are mediators of the pro-myogenic actions of IGF-2.
    Carter EJ; Cosgrove RA; Gonzalez I; Eisemann JH; Lovett FA; Cobb LJ; Pell JM
    J Cell Sci; 2009 Sep; 122(Pt 17):3104-12. PubMed ID: 19654213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HB-EGF induces cardiomyocyte hypertrophy via an ERK5-MEF2A-COX2 signaling pathway.
    Lee KS; Park JH; Lim HJ; Park HY
    Cell Signal; 2011 Jul; 23(7):1100-9. PubMed ID: 21244855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic signaling of MEK5-ERK5.
    Hoang VT; Yan TJ; Cavanaugh JE; Flaherty PT; Beckman BS; Burow ME
    Cancer Lett; 2017 Apr; 392():51-59. PubMed ID: 28153789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.